Check the time stamp on this data. Updated AI-Generated Signals for Catalyst Biosciences Inc. (GYRE) available here: GYRE.

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic organ diseases, today ...

Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report) traded down 4.4% during trading on Tuesday following insider selling ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Gyre ...

圣地亚哥——根据向美国证券交易委员会提交的文件，Gyre Therapeutics, Inc.（纳斯达克股票代码：GYRE）总裁马松江最近出售了部分公司持股。马松江于2025年1月6日和1月7日两天内总共出售了2,216股普通股。根据 InvestingPro 的数据，这些销售发生之际，GYRE股价在过去一周下跌了17%。

Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totalling 832,200 shares, a ...

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated ...

Gyre Therapeutics (GYRE) announced the appointment of Ping Zhang to its Board of Directors as the lead independent director of the Board and a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gyre Therapeutics (GYRE) announced the appointment of Ping Zhang to its Board of Directors as the lead independent director of the Board and a member of the Nominating and Corporate Governance ...